LIFR and pancreatic neoplasm: Among the ligands of LIFR, LIF is overexpressed and has been identified playing a tumor-promoting role in various tumors, including prostate, nasopharyngeal, breast, gastric, endometrial, colorectal, melanoma, osteosarcoma, lung and pancreatic cancers (2–10).